eoxtaxin-3 Activators
Eotaxin-3 Activators are a class of chemical compounds that influence various signaling pathways, culminating in the enhancement of Eotaxin-3 function. Forskolin, by increasing intracellular cAMP levels, leads to the activation of PKA, which has a variety of downstream effects that can enhance the activity of Eotaxin-3. Similarly, PGE2 works through its receptors to raise cAMP levels, consequently activating PKA and favoring Eotaxin-3 signaling. Histamine and Isoproterenol also increase cAMP, thereby activating PKA, which in turn, can promote the signaling environment conducive to Eotaxin-3 activity. IBMX and Rolipram, by inhibiting phosphodiesterases, prevent cAMP degradation, leading to sustained PKA activity that supports Eotaxin-3 function. Apremilast, through similar mechanisms, inhibits phosphodiesterase-4, ensuring elevated cAMP and activated PKA, thereby enhancing Eotaxin-3 pathways.
Additionally, Theophylline and Terbutaline function as non-selective phosphodiesterase inhibitors and beta2-adrenergic receptor agonists, respectively, both leading to increased cAMP and PKA activation, which can enhance Eotaxin-3 signaling. Anisomycin, while primarily known as a protein synthesis inhibitor, can activate JNK signaling, a process that can augment transcriptional events enhancing Eotaxin-3 function. SB 203580 and PD 98059 act as inhibitors of p38 MAPK and MEK, respectively; however, these actions may result in compensatory activation of alternative pathways that could upregulate Eotaxin-3 activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) acts through its EP receptors to increase intracellular cAMP levels, which in turn activates PKA. PKA activation can lead to a cascade of events culminating in the enhancement of Eotaxin-3 activity. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, through the H2 receptor, can elevate cAMP levels, thereby activating PKA. PKA phosphorylates various substrates that can influence the signaling environment to favor Eotaxin-3 activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, leading to PKA activation. This activation enhances signaling pathways that can upregulate Eotaxin-3 function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) inhibits phosphodiesterases, preventing cAMP breakdown, which leads to PKA activation. PKA then contributes to signaling pathways that enhance Eotaxin-3 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective phosphodiesterase-4 inhibitor, leading to increased cAMP and subsequent PKA activation. PKA can then facilitate processes that elevate Eotaxin-3 signaling. | ||||||
Apremilast | 608141-41-9 | sc-480062 | 5 mg | $444.00 | ||
Apremilast inhibits phosphodiesterase-4, increasing cAMP levels, which results in PKA activation. The activated PKA may then enhance the signaling pathways associated with Eotaxin-3 function. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline is a non-selective phosphodiesterase inhibitor that increases cAMP levels, thereby enhancing PKA activity. PKA, in turn, can promote signaling mechanisms that increase the functional activity of Eotaxin-3. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline, a beta2-adrenergic receptor agonist, elevates cAMP levels, leading to PKA activation. This activation can enhance the signaling pathways that regulate Eotaxin-3 function. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor, but it can also activate JNK signaling. Activated JNK can lead to transcriptional events that enhance the expression and function of Eotaxin-3. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a p38 MAPK inhibitor, but its action can cause compensatory activation of alternate MAPK pathways, which might indirectly enhance Eotaxin-3 signaling. | ||||||